BMRN - BioMarin Pharmaceutical Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 514.54B
Enterprise Value 314.61B
Trailing P/E N/A
Forward P/E 1270.70
PEG Ratio (5 yr expected) 1-2.04
Price/Sales (ttm)9.58
Price/Book (mrq)4.95
Enterprise Value/Revenue 39.62
Enterprise Value/EBITDA 6-232.35

Trading Information

Stock Price History

Beta (3Y Monthly) 1.21
52-Week Change 3-19.72%
S&P500 52-Week Change 36.34%
52 Week High 3106.74
52 Week Low 379.13
50-Day Moving Average 383.24
200-Day Moving Average 388.45

Share Statistics

Avg Vol (3 month) 31.33M
Avg Vol (10 day) 3747.28k
Shares Outstanding 5178.25M
Float 178.01M
% Held by Insiders 10.45%
% Held by Institutions 1102.88%
Shares Short (Jun 28, 2019) 49.03M
Short Ratio (Jun 28, 2019) 45.95
Short % of Float (Jun 28, 2019) 45.67%
Short % of Shares Outstanding (Jun 28, 2019) 45.04%
Shares Short (prior month May 31, 2019) 49.11M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -5.90%
Operating Margin (ttm)-10.40%

Management Effectiveness

Return on Assets (ttm)-2.19%
Return on Equity (ttm)-3.12%

Income Statement

Revenue (ttm)1.52B
Revenue Per Share (ttm)8.55
Quarterly Revenue Growth (yoy)7.30%
Gross Profit (ttm)479.62M
EBITDA -62.88M
Net Income Avi to Common (ttm)-89.53M
Diluted EPS (ttm)-0.50
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)894.85M
Total Cash Per Share (mrq)5
Total Debt (mrq)891.93M
Total Debt/Equity (mrq)30.37
Current Ratio (mrq)3.83
Book Value Per Share (mrq)16.40

Cash Flow Statement

Operating Cash Flow (ttm)7.85M
Levered Free Cash Flow (ttm)-46.21M